Market access experts accelerate entry into Europe's neurological drugs market

Discover how a healthcare consultancy used insights gained from experts sourced by Techspert to help their end client launch their neurological drugs portfolio in Europe.

The Challenge

A healthcare strategy consultancy needed rapid access to senior market access experts specializing in pricing and reimbursement for neurological drugs and drug/device combinations.

Their goal was to support an end client’s entry into key European markets, including EU5 (France, Germany, Italy, Spain, UK), Luxembourg, Belgium, and the Netherlands. With a tight timeline, they needed expert interviews to begin within 24 hours.

The Techspert Approach

Techspert’s AI-powered search technology specializes in sourcing precisely matched experts—not just those from static databases. Leveraging our Knowledge Graph, which maps connections between experts, institutions, and key industry topics, we quickly identified and vetted the most relevant market access specialists to speak on this project.

The project delivery team quickly sourced, screened, and scheduled highly relevant, senior-level experts across Europe, ensuring our customer could engage with the right decision-makers on time.

Insights Delivered

Techspert facilitated 60-minute qualitative interviews, equipping the consultancy and their end client with critical insights on the European neurological drugs market. By delivering expert insights at speed, Techspert enabled the consultancy to refine market entry strategies and accelerate decision-making, ensuring a successful European launch for their client’s neurological drug portfolio.

The experts included: 

A Neurology Business Manager at a global biotechnology company with 30 years’ experience in pharmaceutical sales	A Head of Market Access at an international pharmaceutical company with more than 20 years’ experience.	A Neurology PVU (Patient Value Unit) International Markets Team Lead at a global biopharmaceutical company.